![]() |
市场调查报告书
商品编码
1403434
2030 年锭剂包衣市场预测:按聚合物类型、类型、功能、最终用户和地区进行的全球分析Tablet Coatings Market Forecasts to 2030 - Global Analysis By Polymer Type (Cellulosic Polymers, Vinyl Derivatives & Other Polymer Types), By Type (Enteric-coated Tablets, Film-coated Tablets & Other Types), Functionality, End User & By Geography |
根据 Stratistics MRC 的数据,2023 年全球锭剂包衣市场规模为 9.206 亿美元,预计将以 7.6% 的复合年增长率成长,到 2030 年达到 15.373 亿美元。
锭剂包衣是锭剂上的一层薄薄的聚合物或化合物。这些包衣具有多种用途,包括改善外观、掩味、防止水分和光劣化、促进吞嚥、控制药物释放和提高稳定性。它在确保有效的药物传递、优化患者依从性以及保持口服剂型中活性药物成分的完整性方面发挥关键作用。
根据欧洲製药工业和协会联合会2022年的报告,2020年欧洲药品产值为2866.97亿欧元(3074168.80亿美元),2021年为3000亿欧元(3216.813亿美元)。
製药业的快速扩张一直是锭剂包衣市场的关键驱动因素。在不断变化的医疗保健需求和慢性病扩散的推动下,製药业的成长正在推动对先进药物配方的需求。锭剂包覆在提高药物疗效、患者依从性和产品差异化方面发挥着至关重要的作用。此外,随着製药公司追求创新的药物传输系统,包覆可以实现缓释性并推动包覆锭剂的采用。这种扩张为配方改进创造了机会,并推动了锭剂包衣市场的成长。
开发新配方或改进现有涂料需要较长的开发週期和广泛的研究,这会增加成本并阻碍快速进入市场。配方核准和严格测试流程的延迟进一步延长了时间并影响了产品的发布。这些详尽的程序不仅增加了开发成本,而且抑制了及时回应市场需求所需的敏捷性。这种抑制因素可能会限制创新并阻止中小企业进入市场,从而影响整个行业的成长。
不断增加的研发投资为锭剂包覆市场创造了诱人的机会。增加研发投资将促进创新并促进先进涂层材料和技术的发展。研究的激增催生了新的配方,可改善药物输送、提高稳定性并满足特定患者的需求。此外,它还可以创建环境永续的涂料,满足对环保药品日益增长的需求。这种投资的激增不仅将推动市场扩张,还将推动锭剂包覆向更有效率和客製化的解决方案发展。
应对复杂且不断变化的法规对产品开发、核准和市场进入提出了重大挑战。满足严格的品质标准、文件要求和安全评估需要大量资源和时间,从而增加了开发成本。此外,监管变化可能会影响现有产品并需要进行调整。这些障碍阻碍和威胁锭剂包衣行业的成长和竞争力,阻碍创新,限制中小企业进入市场,并可能延迟先进包衣的引进。
COVID-19 的爆发扰乱了供应链并影响了生产计划,从而影响了锭剂被覆剂市场。药品需求的成长正在推动市场发展,但物流问题和劳动力限制等挑战正在影响业务。此外,临床试验和监管流程的延迟也影响了新涂层的推出。该行业透过利用数位技术、强调远端工作和实施安全措施进行了调整,但整体影响凸显了该行业的弹性和适应性。
在预测期内,纤维素聚合物领域因其多功能特性预计将主导锭剂包衣市场。羟丙基甲基纤维素 (HPMC) 和乙基纤维素等纤维素衍生物具有优异的成膜能力、控制释放特性和改进的药物製剂稳定性。其生物相容性、安全性以及与各种药物类型的相容性有助于其广泛采用。此外,对天然和植物来源被覆剂不断增长的需求预计将增强其市场主导地位,因为它们与纤维素聚合物的吸引力一致,使它们成为锭剂被覆剂的首选。
薄膜包衣锭剂预计在预测期内将出现显着增长。薄膜包衣可增强锭剂的美观,掩盖不良味道,防止环境因素影响,并有助于提高患者的依从性。此外,它还可以实现控制释放製剂并实现精确的药物传输。此外,对患者友善剂型的需求不断增长,以及薄膜包衣适应各种药物配方的能力符合当前的製药趋势,并正在推动锭剂包衣市场这一细分市场的成长。
由于其强大的製药基础设施、广泛的研发投资以及对创新药物配方的关注,预计北美将主导锭剂包衣市场。有利的法律规范和高医疗保健支出进一步推动了市场成长。此外,该地区对缓释製剂的需求不断增加,加上慢性病的高发,推动了先进片剂缓释性的锭剂。
由于製药业的扩张、医疗保健支出的增加以及研发投资的增加,预计亚太地区的锭剂包衣市场将出现良好的成长,从而推动市场机会。此外,人口成长、生活方式的改变和慢性疾病的扩散正在推动药品需求并刺激对先进锭剂包衣的需求。此外,大量受託製造厂商(CMO)和发达的医疗保健基础设施也增强了亚太地区的吸引力,增加了该地区锭剂包衣的强劲增长预测。穿上它。
According to Stratistics MRC, the Global Tablet Coatings Market is accounted for $920.6 million in 2023 and is expected to reach $1537.3 million by 2030 growing at a CAGR of 7.6% during the forecast period. Tablet coatings are thin layers of polymers or compounds on pharmaceutical tablets. These coatings serve multiple purposes, such as improving appearance, taste-masking, protecting against moisture or light degradation, facilitating swallowing, controlling drug release, and enhancing stability. They play a vital role in ensuring effective drug delivery, optimizing patient compliance and preserving the integrity of active pharmaceutical ingredients within oral dosage forms.
According to the European Federation of Pharmaceutical Industries and Associations, 2022 report, the production of pharmaceuticals in Europe was valued at EUR 286,697 million (USD 30,7416.88) in 2020 and EUR 300,000 million (USD 321681.30) in 2021.
The rapid expansion of the pharmaceutical sector acts as a significant driver in the tablet coatings market. The pharmaceutical industry's growth, fueled by evolving healthcare needs and a surge in chronic diseases, propels the demand for advanced drug formulations. Tablet coatings play a pivotal role in enhancing drug efficacy, patient compliance and product differentiation. Moreover, as pharmaceutical companies strive for innovative drug delivery systems, coatings enable modified-release formulations, driving the adoption of coated tablets. This expansion creates opportunities for improved formulations, driving the growth of the tablet coatings market.
The lengthy development cycles and extensive research involved in creating new formulations or modifying existing coatings amplify costs and hinder rapid market entry. Delays in formulation approvals and stringent testing processes further extend the timeline, impacting product launches. These exhaustive procedures not only inflate development expenses but also impede the agility needed for timely responses to market demands. This restraint limits innovation and may deter smaller players from entering the market, affecting overall industry growth.
The escalating investment in research and development presents a compelling opportunity in the tablet coatings market. Increased R&D investments drive innovation, fostering the development of advanced coating materials and technologies. This surge in research leads to novel formulations that improve drug delivery, offer enhanced stability, and cater to specific patient needs. Moreover, it enables the creation of eco-friendly and sustainable coatings, aligning with the growing demand for environmentally conscious pharmaceutical products. This investment surge not only fosters market expansion but also promotes the evolution of tablet coatings towards more efficient and tailored solutions.
Compliance with complex and evolving regulations adds significant challenges to product development, approvals and market entry. Meeting stringent quality standards, documentation requirements and safety evaluations demands substantial resources and time increasing development costs. Moreover, changes in regulations can impact existing products, necessitating adaptations. These hurdles hinder innovation, limit market entry for smaller firms and potentially delay the introduction of advanced coatings, posing a threat by impeding growth and competitiveness within the tablet coatings industry.
The COVID-19 pandemic has influenced the tablet coatings market by disrupting supply chains and impacting production schedules. Increased demand for pharmaceuticals has driven the market, but challenges like logistical issues and workforce limitations have affected operations. Furthermore, delays in clinical trials and regulatory processes have impacted the introduction of new coatings. The industry has adapted through digital technologies, emphasizing remote work and implementing safety measures, but the overall impact underscores the sector's resilience and adaptability.
Over the forecast period, the cellulose polymers segment is expected to dominate the tablet coatings market due to their versatile properties. Cellulose derivatives like hydroxypropyl methylcellulose (HPMC) and ethyl cellulose offer excellent film-forming abilities, controlled-release properties and stability enhancement for pharmaceutical formulations. Their biocompatibility, safety, and suitability for various drug types contribute to their widespread adoption. Additionally, the growing demand for natural and plant-based coatings aligns with cellulose polymers' appeal, positioning them as favored choices for tablet coatings, thus driving their anticipated dominance in the market.
During the forecast period, the film-coated tablets segment is poised to witness significant growth. Film coatings enhance the aesthetic appeal of tablets, mask unpleasant tastes and protect against environmental factors, contributing to improved patient compliance. Moreover, they enable controlled-release formulations, ensuring precise drug delivery. Additionally, the rising demand for patient-friendly dosage forms and the ability of film coatings to accommodate various drug formulations align with current pharmaceutical trends, fostering the growth of this segment in the tablet coatings market.
North America is expected to dominate the tablet coatings market due to its robust pharmaceutical infrastructure, extensive R&D investments and strong emphasis on innovative drug formulations. Favorable regulatory frameworks and substantial healthcare expenditures further drive market growth. Additionally, the region's increasing demand for modified-release formulations, coupled with a high prevalence of chronic diseases, fuels the adoption of advanced tablet coatings.
Asia Pacific is poised to register lucrative growth in the tablet coatings market owing to the region's expanding pharmaceutical sector, rising healthcare expenditures, and increasing investments in R&D, which foster market opportunities. Additionally, a growing population, changing lifestyles and a surge in chronic diseases drive demand for pharmaceuticals, stimulating the need for advanced tablet coatings. Furthermore, the presence of a large pool of contract manufacturing organizations (CMOs) and improving healthcare infrastructure contribute to the region's attractiveness, fueling the projected robust growth of tablet coatings in Asia Pacific.
Some of the key players in tablet coatings market include Ashland Global Holdings Inc., BASF SE, Clariant AG, Coating Place, Inc., Colorcon, DOW Inc., DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., Ideal Cures Pvt. Ltd., JRS Pharma, Kerry Group, Merck KGaA, PPG Industries, Inc., Roquette Freres, Sensient Technologies Corporation and Shin-Etsu Chemical Co., Ltd.
In March 2023, Colorcon announced the launch of its new Soluplus® Encapsulation Technology. This technology is designed to improve the solubility and bioavailability of poorly water-soluble drugs.
In February 2023, Sensient Technologies announced the expansion of its tablet coating capabilities in the US. The company is investing $10 million in the expansion, which is expected to be completed by the end of 2023. The expansion will increase the company's tablet coating capacity by 50%.
In February 2022, JRS PHARMA introduced the solution for Titanium Dioxide free ready-to-use coatings, VIVACOAT® free.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.